Rare diseases
Investigational molecules
Locations
Herengracht 540, 1017 CG Amsterdam, The Netherlands
Research activity is centered on epilepsy, with emphasis on focal onset seizures in people receiving ongoing anti-seizure medication. The sponsor’s clinical interest lies in adjunctive therapy for seizure control and symptom management.
The sponsor is active across multiple research sites in Europe and other countries, with clinical work focused on treatment options for individuals whose seizures persist despite standard medication.
Equilibre Biopharmaceuticals B.V. runs clinical trials in conditions such as Partial seizures, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
